Skip to main content

Table 1 Clinical and demographic characteristics at baseline

From: Influence of glucocorticoid treatment on trabecular bone score and bone remodeling regulators in early rheumatoid arthritis

Parameter

 

Sex, female, n (%)

38 (80.8%)

Age (years)

38.33 ± 7.03

DAS28

3.65 ± 0.71

Smokers, n (%)

11 (23.4%)

Alcohol

25 (53.1%)

ACPA, n (%)

44 (93.6%)

RF, n (%)

42 (89.36%)

BMI

23.64 ± 2.62

BMD spine (g/cm2)

0.877 ± 0.1

BMD femoral neck (g/cm2)

0.795 ± 0.1

BMD total hip (g/cm2)

0.854 ± 0.108

TBS

1.357 ± 0.401

Sclerostin (pg/ml)

285.6 ± 40.38

Dkk-1 (pg/ml)

3710.06 ± 772.7

OPG (pg/ml)

443.45 ± 80.57

RANKL (pg/ml)

277.74 ± 79.6

OPG/RANKL

1.83 ± 0.89

  1. ACPA, anti-citrullinated protein antibody; RF, rheumatoid factor BMI, body mass index; BMD, bone mineral density; TBS, trabecular bone score; Dkk-1, Dickkopf; OPG, osteoprotegerin; RANKL, nuclear factor kappa-Î’ ligand